Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03789786 · ClinicalTrials.gov registry record
Long-term Outcomes of Selective Dorsal Rhizotomy Among Individuals With Cerebral Palsy
A clinical trial, sponsored by Gillette Children's Specialty Healthcare.
- Completed
- Registry status
- 78
- Enrollment target
NCT03789786: Completed study, sponsored by Gillette Children's Specialty Healthcare.
NCT03789786 is a clinical trial that has completed, run by Gillette Children's Specialty Healthcare. The registered enrollment target is 78 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03789786 has completed, sponsored by Gillette Children's Specialty Healthcare.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
Study Summary
Spasticity affects up to 80% of individuals diagnosed with cerebral palsy. Selective dorsal rhizotomy (SDR) is a surgical method used by some hospitals to permanently reduce spasticity in order to prevent further morbidities. Better understanding of the long-term outcomes of SDR is essential for clinicians and families. The results of this study will have direct clinical impact by equipping providers with the necessary information to counsel families during medical decision making.
Primary Outcome
Compare three-dimensional gait kinematics and kinetics across groups
Interventions
- BEHAVIORAL Surveys
- DIAGNOSTIC_TEST Gait and Motion Analysis
- DIAGNOSTIC_TEST Gross Motor Function Measure (GMFM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2020-01-31 |
What the finished NCT03789786 record still lists
NCT03789786 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Surveys is the first listed.
NCT03789786 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03789786 about?
NCT03789786 is a clinical study titled "Long-term Outcomes of Selective Dorsal Rhizotomy Among Individuals With Cerebral Palsy". Spasticity affects up to 80% of individuals diagnosed with cerebral palsy. Selective dorsal rhizotomy (SDR) is a surgical method used by some hospitals to permanently reduce spasticity in order to prevent further morbidities. Better understanding of the long-term outcomes of SDR is essential for cli...
What is the current status of trial NCT03789786?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2018-11-01. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT03789786?
The interventions under investigation include: Surveys (BEHAVIORAL), Gait and Motion Analysis (DIAGNOSTIC_TEST), Gross Motor Function Measure (GMFM) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03789786?
This trial is sponsored by Gillette Children's Specialty Healthcare, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI